These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2540057)

  • 21. The alpha adrenergic response of Down's syndrome platelets.
    Sheppard JR; Schumacher W; White JG; Jakobs KH; Schultz G
    J Pharmacol Exp Ther; 1983 Jun; 225(3):584-8. PubMed ID: 6306212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG; O'Barr TP
    Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations.
    Motulsky HJ; Insel PA
    N Engl J Med; 1982 Jul; 307(1):18-29. PubMed ID: 6123082
    [No Abstract]   [Full Text] [Related]  

  • 24. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
    Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors.
    Lefkowitz RJ; Caron MG; Stiles GL
    N Engl J Med; 1984 Jun; 310(24):1570-9. PubMed ID: 6145093
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M; Zahavi J; Kakkar VV
    Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial comments: cyclic nucleotides and the pathophysiology of the cardiovascular system.
    Sands H
    Adv Cyclic Nucleotide Res; 1980; 12():93-5. PubMed ID: 6250377
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet aggregation and beta-blockers.
    Hansen KW; Klysner R; Geisler A; Knudsen JB; Glazer S; Gormsen J
    Lancet; 1982 Jan; 1(8265):224-5. PubMed ID: 6119584
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood coagulation and fibrinolysis].
    Matsuda T
    Nihon Rinsho; 1973 Sep; 31(9):2734-8. PubMed ID: 4148965
    [No Abstract]   [Full Text] [Related]  

  • 30. [Platelet adhesion, aggregation and liberation and cyclic nucleotide level in patients with leukemia].
    Han ZC
    Zhonghua Yi Xue Za Zhi; 1985 Dec; 65(12):739-42. PubMed ID: 3011227
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood platelet cyclic AMP during long-term treatment of premature labor.
    Göser R; Briel RC; Breisch G; Jaschonek K; Schindler AE
    Arch Gynecol; 1980; 230(1):89-94. PubMed ID: 6254451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man.
    Jones CR; Giembcyz M; Hamilton CA; Rodger IW; Whyte K; Deighton N; Elliott HL; Reid JL
    Clin Sci (Lond); 1986 Feb; 70(2):147-53. PubMed ID: 2869850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW; Cooper B; Handin RI
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is prostacyclin a physiologically important circulating anti-platelet agent?
    Steer ML; MacIntyre DE; Levine L; Salzman EW
    Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic 3',5'-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic amp in platelet function.
    Salzman EW; Kensler PC; Levine L
    Ann N Y Acad Sci; 1972 Oct; 201():61-71. PubMed ID: 4346063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of alpha 2-adrenoceptor regulation in brain and platelets.
    Hamilton CA; Jones CR; Mishra N; Barr S; Reid JL
    Brain Res; 1985 Nov; 347(2):350-3. PubMed ID: 4063813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down regulation of alpha 2 adrenergic receptor numbers in platelets by insulin.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1992 Apr; 1134(3):292-6. PubMed ID: 1313699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Platelet Aggregation Modulators on Cyclic AMP Production in Human Thrombocytes.
    Boyanov KO; Maneva AI
    Folia Med (Plovdiv); 2018 Jun; 60(2):241-247. PubMed ID: 30355828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of "Beijing Composite Recipe No. 2 for coronary disease" on cAMP content of washed rabbit platelets (author's transl)].
    Shi QH; Zhang ZR; An Y; Zhu GQ; Wang Z; Liu JS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Dec; 2(4):254-8. PubMed ID: 6273002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.